The FDA approved Zepbound (tirzepatide) injection for chronic weight management in adults with obesity or overweight with at least one weight-related condition, for use in addition to a reduced calorie diet and increased physical activity.
FDA approves Zepbound, a new obesity drug that will take on Wegovy wprl.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wprl.org Daily Mail and Mail on Sunday newspapers.
The approval means tirzepatide could be covered by most insurance plans, making it more affordable for millions of patients and likely adding to the massive demand for weight loss drugs like Wegovy and Ozempic.
The approval means tirzepatide could be covered by most insurance plans, making it more affordable for millions of patients and likely adding to the massive demand for weight loss drugs like Wegovy and Ozempic.
The approval means tirzepatide could be covered by most insurance plans, making it more affordable for millions of patients and likely adding to the massive demand for weight loss drugs like Wegovy and Ozempic.